DeepMed Research

CDC ENTEBBE

🇺🇬Uganda

Country: 🇺🇬Uganda

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Open Label Extension (OLE) of the TDF2 Study, Botswana

Not Applicable

Completed

Conditions: HIV Infections

Interventions: Drug: Tenofovir Disoproxil Fumarate 300 mg + Emtricitabine 200 mg

First Posted Date: 2020-03-23

Last Posted Date: 2022-05-13

Lead Sponsor: Centers for Disease Control and Prevention

Target Recruit Count: 229

Registration Number: NCT04318210

Evaluating a Caregiver SMS Reminder Intervention to Reduce Immunization Drop-out in Arua, Uganda

Not Applicable

Completed

Conditions: Diphtheria
Pertussis
Polio
Haemophilus Influenzae Type b Infection
Tetanus
Measles
Hepatitis B

Interventions: Behavioral: SMS text reminders

First Posted Date: 2019-11-26

Last Posted Date: 2019-11-26

Lead Sponsor: Centers for Disease Control and Prevention

Target Recruit Count: 1962

Registration Number: NCT04177485

Assessing the Impact of Group Antenatal Care on IPTp Uptake in Tanzania

Not Applicable

Terminated

Conditions: Malaria
Malaria in Pregnancy

Interventions: Other: Group antenatal care (GANC)
Other: Standard antenatal care

First Posted Date: 2019-11-01

Last Posted Date: 2021-07-29

Lead Sponsor: Centers for Disease Control and Prevention

Target Recruit Count: 4515

Registration Number: NCT04148690

Locations: 🇹🇿
Chato District Hospital, Chato, Tanzania

Immunogenicity of Intramuscular and Intradermal IPV

Phase 4

Terminated

Conditions: Poliomyelitis

Interventions: Biological: fIPV (0.1 mL) ID
Biological: fIPV (0.1mL) IM
Biological: fIPV (0.2mL) IM
Biological: IPV

First Posted Date: 2019-08-21

Last Posted Date: 2022-05-18

Lead Sponsor: Centers for Disease Control and Prevention

Target Recruit Count: 958

Registration Number: NCT04063150

Locations: 🇧🇩
icddr,b study clinics (Mirpur and CTU Dhaka), Dhaka, Bangladesh

Just-in-time Elastomeric Training and Fit Testing (JET FIT)

Not Applicable

Completed

Conditions: Infection

Interventions: Other: Reusable respirator fit test and competency evaluation
Other: Control fit test evaluation

First Posted Date: 2019-03-25

Last Posted Date: 2023-05-19

Lead Sponsor: Centers for Disease Control and Prevention

Target Recruit Count: 300

Registration Number: NCT03888898

Locations: 🇺🇸
University of Texas, Houston, Texas, United States
🇺🇸
Wayne State University, Detroit, Michigan, United States
🇺🇸
Emory University, Atlanta, Georgia, United States

Tuberculosis Clinical Trials Consortium Study 35

Phase 1

Recruiting

Conditions: Latent Tuberculosis

Interventions: Drug: Rifapentine
Drug: Isoniazid

First Posted Date: 2018-11-05

Last Posted Date: 2023-09-01

Lead Sponsor: Centers for Disease Control and Prevention

Target Recruit Count: 72

Registration Number: NCT03730181

Locations: 🇿🇦
Desmond Tutu TB Center, University of Stellenbosch, Stellenbosch, South Africa

Immunogenicity of Fractional One-fifth and One-half Doses of Yellow Fever Vaccine Compared to Full Dose in Children 9-23 Months Old

Phase 4

Completed

Conditions: Yellow Fever

Interventions: Biological: Yellow Fever 17DD Vaccine

First Posted Date: 2018-10-31

Last Posted Date: 2025-04-08

Lead Sponsor: Centers for Disease Control and Prevention

Target Recruit Count: 1788

Registration Number: NCT03725618

Locations: 🇺🇸
Centers for Disease Control and Prevention, Atlanta, Georgia, United States

Immunogenicity Trial of Egg- Versus Non-Egg-Based Influenza Vaccines Among HCP

Phase 4

Completed

Conditions: Influenza

Interventions: Biological: Flucelvax
Biological: Fluarix
Biological: Flublok
Biological: Fluzone High-Dose
Biological: Fluzone

First Posted Date: 2018-10-29

Last Posted Date: 2024-07-22

Lead Sponsor: Centers for Disease Control and Prevention

Target Recruit Count: 944

Registration Number: NCT03722589

Locations: 🇺🇸
Kaiser Permanente Northwest, Portland, Oregon, United States
🇺🇸
Baylor Scott and White Health, Temple, Texas, United States

Monovalent Oral Poliovirus Vaccine Type 1 Intestinal and Humoral Immunity Study

Phase 4

Completed

Conditions: Poliomyelitis

Interventions: Biological: mOPV1
Biological: bOPV
Biological: fIPV

First Posted Date: 2018-10-26

Last Posted Date: 2021-02-21

Lead Sponsor: Centers for Disease Control and Prevention

Target Recruit Count: 1256

Registration Number: NCT03722004

Locations: 🇧🇩
icddr,b study clinics (Mirpur and CTU Dhaka), Dhaka, Bangladesh

Efficacy of 3 Regimens of Chloroquine and Primaquine for Treatment of P. Vivax Malaria, Cruzeiro do Sul, Acre, Brazil

Not Applicable

Completed

Conditions: Malaria, Vivax
P Vivax

Interventions: Drug: Primaquine

First Posted Date: 2018-08-01

Last Posted Date: 2021-08-09

Lead Sponsor: Centers for Disease Control and Prevention

Target Recruit Count: 257

Registration Number: NCT03610399

Locations: 🇧🇷
Hospital do Jurua, Cruzeiro do Sul, Brazil

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy